2. PARACETAMOL
(ACETAMINOPHEN)
• Non-steroidal anti-inflammatory drug(NSAID)
• Has analgesic and antipyretic effects but weak anti-inflammatory
properties
• Exerts its effects through the inhibition of cyclo-oxygenase (COX)
• COX catalyses the formation of prostaglandins (PGs) and other
mediators that are important in the processing and signaling of
pain and control of the thermoregulatory center of the brain.
3. PHARMACOKINETICS
• Oral acetaminophen has excellent bioavailability
• Peak plasma concentration occur within 30 to 60 minutes
• The half-life in plasma is about 2 hours after therapeutic doses
4. METABOLISM
• Metabolized in the liver by conjugation with sulfate or
glucuronate (90%), and by CYP2E1 enzymes(5%), and the
remainder is secreted unchanged in the urine(5%)
• The CYP2E1 enzyme pathway is the basis for
acetaminophen toxicity
5. DOSE OF PARACETAMOL
• Therapeutic dose is 10-15 mg/kg
Toxic dose:
• More than 7.5 gm (around 15 tablets) – minimal toxicity,
severe liver toxicity if > 15gms (30 tablets)
• In adults toxic dose is 150mg/kg
• In children under 12 years toxic dose is 200mg/kg
• In the presence of chronic liver disease or malnutrition, even
2g of PCM can be a toxic dose
6. MECHANISM OF TOXICITY
• When the dose of paracetamol is high
• The glucuronide and sulfate conjugation pathways become
saturated, and increasing amounts undergo CYP-mediated N-
hydroxylation to form N-acetyl-para- benzoquinoneminine
(NAPQI)
• Eliminated rapidly by conjugation with glutathione (GSH) and
then further metabolized to a mercapturic acid and excreted
into the urine
• In acetaminophen overdose, hepatocellular levels of GSH
become depleted.
7. CONTD…
• The highly reactive NAPQI metabolite binds covalently to
cell macromolecules, leading to dysfunction of enzymatic
systems and structural and metabolic disarray
• Depletion of intracellular GSH renders the hepatocytes
highly susceptible to oxidative stress and apoptosis.
• Binding covalently to cellular proteins, causes cell death
8. HEPATOTOXICITY:
• In adults, hepatotoxicity may occur after ingestion of a single
dose of 10 to 15 g (150 to 250 mg/kg) of acetaminophen
• Doses of 20 to 25 g or more are potentially fatal
High risk people:
• Conditions of CYP induction (e.g. heavy alcohol consumption,
those on anticonvulsant drugs)
• Condition of GSH depletion (e.g. fasting or malnutrition)
• With pre-existing liver disease
• Those suffering from anorexia nervosa and other eating
disorders &
• HIV infection
9. PHASES OF
INTOXICATION
1) Stage 1 (time of ingestion to 24 hours) :
• Patient typically has anorexia, nausea, vomiting, and diaphoresis
• Results of laboratory tests are usually normal
2) Stage 2 (24-72 hours):
• Results of laboratory tests begin to be abnormal
• Abnormalities include increases in serum transaminases,
bilirubin and PT
• Nephrotoxicity may be evident
10. CONTD…
3) Stage 3 (72 to 96 hours):
• Also known as hepatic stage
• Severe signs of hepatotoxicity appear
• This includes:
Plasma ALT and AST levels often >10,000 IU/L, increased in PT or INR
Hypoglycemia
Lactic acidosis and
A total bilirubin concentration above 70umole/l (primarily indirect)
• Death most commonly occurs in this stage, usually from multiorgan
system failure.
11. CONTD…
4) Stage 4 (4 days-2 weeks) :
• Is the recovery stage
• Patients who survive stage III enter a recovery phase that
usually begins by day 4 and is complete by 7 days after
overdose
• However, transient renal failure may develop 5-7 days after
ingestion (Back pain, proteinuria, hematuria)
• Complete hepatic recovery may take 3-6 months.
12. APPROACH TO THE
PATIENT
• ABCDE
• History
• Examination
• Investigations
• Initial baseline investigations
• LFT, PT/INR, blood glucose, platelet count, electrolyte, urine
routine
• Plasma paracetamol level
• Determined after 4 hours of ingestion
13. MANAGEMENT
1) Activated charcoal may be used in patients presenting within
1 hour.
2) Antidotes for paracetamol poisoning
a. N-acetylcysteine (NAC)
b. Methioinine
Act by replenishing hepatic glutathione
N-acetyl cysteine may also repair oxidation damage caused
by NAPQI
15. N-ACETYLCYSTEINE (NAC)
• IV is highly efficacious if administered within 8 hours of the
overdose
• Should not be delayed in patients presenting after 8 hours
to await a paracetamol blood concentration result.
Dose:
• 150mg/kg in 200 ml 5% dextrose over 15 minutes
• Followed by 50mg/kg in 500 ml 5% dextrose over 4
hours
• Followed by 100mg/kg in 1000 ml 5% dextrose over 16
hours
16. CONTD…
• Can be stopped if the paracetamol concentration comes below
the appropriate treatment line.
• Important adverse effect is related to dose-related histamine
release
• The ‘anaphylactoid’ reaction - itching and urticaria, and in severe
cases, bronchospasm and hypotension, angio-edema
• Managed by temporary discontinuation of acetylcysteine and
administration of a antihistamine
• Chlorpheniramine 10-20 mg i.v. in an adult may be given
17. METHIONINE
• An alternative antidote in paracetamol poisoning
• 2.5 g orally 4-hourly to a total of four doses
• Less effective, especially after delayed presentation
18. CONTD….
• If patient presents after 15 hours of ingestion
LFTs,PT, RFT measure and antidote started
• Severe liver function abnormality Arterial blood gas
sample taken
• Liver transplantation should be considered in patient if liver
failure due to paracetamol poisoning
21. ANTIDOTE REGIMENS FOR
PARACETAMOL POISONING
N -acetylcysteine (intravenously)
• 150 mg/kg over 15 min, then 50 mg/kg in 500 mL of 5% dextrose in the
next 4 hours and 100 mg/kg in 1000 mL of 5% dextrose over the
ensuing 16 hours.
• Injection Vitamin K 10 mg iv
• Total dose: 300 mg/kg over 20-25 hours.
Methionine (orally)
• 2.5 g initially, then 2.5 g 4-hourly for a further three doses.
• Total dose: 10 g methionine over 12 hours.
N -acetylcysteine (orally)
• 140 mg/kg initially, then 60 mg/kg every 4 hours for 17 additional
doses.
• Total dose: 1330 mg/kg over 72 hours
22. REFERENCES:
• Tintinallis Emergency Medicine, A Comprehensive Study
Guide 7th edition
• Kumar and Clark's clinical medicine, 8thedition
• Goodman & Gilman‘s pharmacological basis of therapeutics
- 11th edition